The expression of vimentin in HL-60 cells induced with etoposide using immunofluorescence and immunogold methods

Polish Journal of Pathology

Volumn 52, Issue 4, 2001, Pages 187-192

  Grzanka, Alina ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL DEATH; CELL STRAIN HL 60; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOGOLD STAINING; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CELL SIZE; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; FLUORESCENT ANTIBODY TECHNIQUE; HL-60 CELLS; HUMANS; MICROSCOPY, IMMUNOELECTRON; VIMENTIN;

EID: 0035705742     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Apoptosis: Mechanism and roles in pathology
2. Improved methods for preserving macromolecular structures and visualizing them by fluorescence and scanning electron microscopy
3. Cytoskeleton-associated proteins: Their role as cellular integrators in the neoplastic process
4. Differential induction of secondary DAN fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression
5. Liu LF Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II
6. Taxol induces concomitant hyperphosphorylation and reorganization of vimentin intermediate filaments in 9L rat brain tumor cells
7. Alteration of vimentin intermediate filaments expression during differentiation of HL-60 and U-937 human leukemic cell lines
8. Cytotoxic mechanism and antineoplastic action of etoposide
9. Assembly of keratin onto PtK cytoskeletons: Evidence for an intermediate filament organizing center
10. Intermediate filaments: Structure, dynamics, function and disease
11. Constitutes an intermediate filament attachment site on the nuclear envelope
12. The expression of proliferating cell nuclear antigen (PCNA) in leukemia cell lines HL-60 and K-562 at the light and electron microscope level
13. Immunogold labelling of PCNA and Ki-67 antigen at the ultrastructural level in laryngeal squamous cell carcinoma and its correlation with lymph node metastasis and histological grade
14. Nuclear dot-like structure that has a relationship with perinuclear intermediate filaments
15. Microtubules, membrane traffic, and cell organization
16. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other anticancer drugs: A cautionary note
17. Changes in microtubules, microtubule-associated proteins, and intermediate filaments during the differentiation of HL-60 leukemia cells
18. Actin polymerization and depolymerization during apoptosis in HL-60 cells
19. DNA topoisomerase poisons as antitumor drugs
20. Mechanism of antitumor drug action: Poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide
21. The expression of tissue transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis)
22. Structure and function of the perinuclear cytoskeleton
23. Differential modulation of the expression of the intermediate filament proteins vimentin and nuclear lamins A and C by differentiation inducers in human myeloid leukemia (U-937, HL-60) cells
24. Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: Induction of vimentin gene expression
25. DNA topoisomerases as targets for chemotherapy
26. Review of etoposide single-agentactivity
27. Apoptosis of human leukemic HL-60 cells induced to differentiate by phorbol ester treatment
28. Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells